Drug intelligence / Profile preview

CLXR-004

Development stage
Unknown
Lead developer
Cardiogeni
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intramyocardial
01

Overview

CLXR-004 is an investigational, off-the-shelf cell therapy being developed by Cardiogeni for the treatment of severe heart failure. The therapy consists of induced Myogenic Progenitor (iMP) cells derived from induced pluripotent stem cells (iPSCs). These progenitor cells are designed to differentiate into functional cardiomyocytes upon delivery, aiming to regenerate damaged heart muscle and restore cardiac output. CLXR-004 is specifically intended for use in patients with end-stage heart failure who are receiving a Left Ventricular Assist Device (LVAD), with the goal of promoting myocardial recovery to the point where the device can potentially be weaned. It is currently in Phase 1 development and has been granted orphan drug designation for this indication.

Other names
iMP cell therapyinduced Myogenic Progenitor cell therapy

Beyond the preview

Go deeper on CLXR-004.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLXR-004.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call